8:45 AM
 | 
Feb 12, 2018
 |  BC Extra  |  Preclinical News

HDAC3 inhibition promotes peripheral remyelination

A study published in Nature Medicine identified histone deacetylase 3 (HDAC3) as a target for boosting remyelination in peripheral neuropathies.

Following demyelination in a mouse model of sciatic nerve injury, researchers from Cincinnati Children’s Hospital Medical Center and colleagues showed...

Read the full 181 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >